List view / Grid view
25 June 2019 | By European Pharmaceutical Review
The process of manufacturing a biotherapeutic drug entails numerous quality control measures to ensure safety and efficacy. The articles in this in-depth focus discuss higher order structure analysis and host cell protein contamination issues.
25 June 2019 | By European Pharmaceutical Review
The latest research and developments from Pharma and Biopharma industry experts.
20 June 2019 | By European Pharmaceutical Review
In this issue we explore reasons behind critical key drug shortages in the EU, whether viability methods effectively detect all viable organisms and how companies can future-proof their digital technologies ahead of Brexit. Also included are articles on higher order protein structure, FMD compliance and Raman spectroscopy.
4 June 2019 | By European Pharmaceutical Review
The global biobetters market is set to increase due to demand for higher efficacy and safer drugs.
30 May 2019 | By European Pharmaceutical Review
British Columbia has said it will switch as many as 20,400 patients from three branded biologic drugs to cheap biosimilars.
20 May 2019 | By Bruce Yu - University of Maryland School of Pharmacy, Wei Xu - Merck & Co, Yongchao Su - Merck & Co
An important step in the research and development of biopharmaceuticals is to identify molecules with favourable physical and chemical stability profiles. Yongchao Su, Wei Xu and Bruce Yu discuss how solution, solid-state and benchtop nuclear magnetic resonance (NMR) methods can provide advanced biophysical characterisations of biological products.
17 May 2019 | By European Pharmaceutical Review
The single-use bioprocessing systems market in Asia Pacific has witnessed an impressive rise and is expected to continue growing.
15 May 2019 | By ACD/Labs
Katalyst D2D is a new software application from ACD/Labs that makes the planning, execution and analysis of high-throughput, parallel experiments easier than ever before. Katalyst is a web-based digital environment that integrates with existing informatics systems, lab automation hardware, analytical instrumentation and automated execution systems for an efficient, streamlined workflow.
14 May 2019 | By Nelson Labs
Nelson Labs has a long history of partnering with pharmaceutical and biopharmaceutical companies. We perform a variety of testing to support your internal quality processes including: sterility (USP 71) testing in a cleanroom for isolator environment, particulates testing (USP 787, 788) using a variety of methods, bacterial endotoxin, filter validations,…
13 May 2019 | By Unjulie Bhanot
There are many business challenges to developing a biologics drug, one of which is effective data management. In this article, Unjulie Bhanot focuses on efficient data management policies and systems, and how they could improve biologics product development processes.
13 May 2019 | By Mike Wilson - Director Product Marketing Mass Spectrometry Systems
Biopharma developers and manufacturers need to know their molecules and understand their manufacturing processes better than ever before. In this article, Mike Wilson discusses the benefits of mass analysis in biopharma and the current challenges of adopting new technologies.
10 May 2019 | By Eurofins
From starting materials through to finished product testing, Eurofins BioPharma Product Testing’s 34 facilities in 17 countries deliver a comprehensive scope of harmonised GMP testing services and seamless regulatory acceptance.
8 May 2019 | By Sartorius
Leading international partner to the biopharmaceutical industry Sartorius Stedim Biotech (SSB) has today announced that the new SIMCA® 16 software for multivariate data analytics is available from its subsidiary Sartorius Stedim Data Analytics.
8 May 2019 | By Wickham Laboratories
Wickham Laboratories Ltd, backed by five decades of global experience in GMP/GLP-regulated laboratory services, is an established name in the fields of pharmaceutical and medical device contract testing, research and consultancy.
Follow: